Characteristics | Before matching | After matching | ||||
---|---|---|---|---|---|---|
Cancer group (n = 51) | Control group (n = 5497) | P value | Cancer group (n = 51) | Control group (n = 204) | P value | |
Age, median | 47 | 35 | < 0.0001 | 47 | 46 | 0.69 |
Female gender, n (%) | 49, 96.08 | 4930, 89.68 | 0.2055 | 49, 96.08 | 192,94.12 | 0.74 |
Age at SLE diagnosis, median | 41 | 33 | 0.0024 | 41 | 39 | 0.96 |
Disease course of SLE, median | 60 | 6 | < 0.0001 | 60 | 60 | 0.92 |
Hypertension | 5, 9.80% | 199, 3.620% | 0.0195 | 5, 9.80% | 15, 7.35% | 0.56 |
Diabetes mellitus | 5, 9.80% | 189, 3.438% | 0.0375 | 5, 9.80% | 14, 6.86% | 0.55 |
Dyslipidemia | 8, 15.38% | 494, 8.18% | 0.0969 | 8, 15.38% | 28, 13.72% | 0.72 |